Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-01-16 @ 5:41 PM
Study NCT ID:
NCT02734693
Status:
COMPLETED
Last Update Posted:
2020-03-27
First Post:
2016-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-01
First Submit QC Date:
None
Study First Post Date:
2016-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-04
Results First Submit QC Date:
None
Results First Post Date:
2020-03-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-01-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-03-16
Last Update Post Date:
2020-03-27
Last Update Post Date Type:
ACTUAL